Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis (Q41653123)

6 October 2017

Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 October 2017

0 references

1 reference

1 reference

Andrew A Taitano

1

1 reference

6 October 2017

Michael Markow

2

1 reference

6 October 2017

Jon E Finan

3

1 reference

6 October 2017

Donald E Wheeler

4

1 reference

6 October 2017

John Paul Gonzalvo

5

1 reference

6 October 2017

Michel M Murr

6

1 reference

6 October 2017

24 December 2014

1 reference

Journal of Gastrointestinal Surgery

6 October 2017

1 reference

6 October 2017

19

1 reference

6 October 2017

3

1 reference

6 October 2017

429-36; discussion 436-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-014-2678-y

6 October 2017

0 references

cites work

Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Non-alcoholic fatty liver disease: what's new under the microscope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Pathogenesis and management issues for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Does LKB1 mediate activation of hepatic AMP-protein kinase (AMPK) and sirtuin1 (SIRT1) after Roux-en-Y gastric bypass in obese rats?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Diet-induced obesity associated with steatosis, oxidative stress, and inflammation in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Roux-en-Y gastric bypass improves hepatic mitochondrial function in obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2678-Y

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

12 December 2020

Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery

1 reference

12 December 2020

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

1 reference

12 December 2020

Regression of hepatic steatosis in morbidly obese persons after gastric bypass

1 reference

12 December 2020

Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients

1 reference

12 December 2020

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

12 December 2020

The epidemiology of nonalcoholic fatty liver disease in adults

1 reference

12 December 2020

10.1007/S11605-014-2678-Y

Identifiers

DOI

1 reference

6 October 2017

1 reference